Abstract
Introduction Immunization is the most cost effective health intervention in the history of mankind. Its role in reducing the morbidities and mortality due to vaccine-preventable diseases is significant. Despite vaccines being important in saving lives; adverse events following immunization (AEFI) do occur that need prompt detection, management, and then reported, analyzed, and the findings being shared with all stakeholders to ensure vaccine safety. The reporting of AEFI in Tanzania is still low. Health Care Providers (HCPs) are obliged to collect and report AEFI. This study assessed the knowledge, attitude, and practices of reporting AEFI among HCPs in Simiyu region, Tanzania.
Methodology This cross-sectional study was conducted between May and June 2024. A total of 180 HCPs were enrolled, structured questionnaire was used to assess the knowledge, attitude, and practices of reporting AEFI among HCPs at primary health facilities. Statistical Package for Social Science (SPSS) was used for entry and data analysis, and the findings were summarized using frequency and percentages. Chi-square test was used to screen for factors associated with AEFI reporting while Poisson regression model was used to confirm the determinants.
Results The median age of study participants was 32 (Inter Quartile Range; 29, 38) years. Among the HCPs, more than one quarter (28.89%) had adequate knowledge of reporting AEFI, and more than half (68.89%) had positive attitudes and good practices (62.22%) of reporting AEFI. Less than half of HCPs (48.3%) had encountered AEFI cases, and about two-thirds (69%) reported it.
Conclusions and recommendations Despite the inadequacy of knowledge on reporting AEFI among HCPs, the attitude and practices of reporting AEFI among HCPs were promising. Based on the study findings, we recommend more training on vaccine surveillance, routine follow-up, and supportive supervision of AEFI surveillance for optimal AEFI reporting and vaccine safety surveillance in Tanzania.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Muhimbili University of Health and Allied Sciences-Tanzania, gave the ethical approval for this work dated 5th March 2024 ref.No.DA.282/298/06/C/767
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
